USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
EYES OF THE WORLD MEDIA GROUP, INC.
Address:
10825 WASHINGTON BLVD
CULVER CITY, CA 90232-3618
Phone:
N/A
URL:
N/A
EIN:
126065058
DUNS:
5365290
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $555,179.00 3

Award List:

A Web-Based Multimedia Resource for Prescription Opiate Treatment

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$149,800.00
Agency:
HHS
Principal Investigator:
Emily Meyers – 310-876-3686
Abstract:
DESCRIPTION (provided by applicant): A Web-Based Multimedia Resource for Prescription Opiate Treatment: Epidemiological data clearly indicate that the abuse of prescription opiates is a major public health problem. Buprenorphine is an important medicationthat offers great promise in treating… More

RxFX - A Mobile Application to Prevent Misuse of Prescription Drugs

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$202,955.00
Agency:
HHS
Principal Investigator:
Emily Meyers – 310-876-3686
Abstract:
DESCRIPTION (provided by applicant): The availability of prescription medications, coupled with misconceptions about their safety and addictive potential, has contributed to the surge in prescription (primarily opioid painkillers) misuse, abuse, dependence, and overdose, and to the death of college… More

iDecide: A Mobile Decision Support Tool Used for Adjuvant Therapy

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$202,424.00
Agency:
HHS
Principal Investigator:
Emily Meyers – 310-876-3686
Abstract:
DESCRIPTION (provided by applicant): Breast cancer remains a leading cause of cancer deaths among women worldwide. Recurrence of cancer is 10-20% within 10 years after surgery and up to 60% or higher in patients with more aggressive cancers. Determining the best adjuvant therapy for an individual is… More